Skip to content

A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-516878-30-00
Acronym
MK-6916-003
Enrollment
16
Registered
2024-12-03
Start date
2024-12-10
Completion date
2025-04-08
Last updated
2024-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and chronic Pain

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026